News

It's official! CVIR Endovascular now has an impact factor of 1.2, a historic development for the journal. We would like to thank all authors, reviewers, editors, and readers for your support over the years.

CVIR Endovascular now follows the same structure for references and citations as CVIR. Numbered references and Vancouver-style citations should now be used for your submission to the journal.

In doubt, you can always check our instructions for authors and the specific submission guidelines for each journal type.

We opened applications for the Reviewer Forum this year and after more than 120 interested applicants reached out. We would like to congratulate the following new members who have been accepted:

The following members of the CVIR Endovascular Reviewer Forum were promoted in July 2021 and invited to become a member of the CVIR Endovascular Editorial Board, after fulfilling their duties as senior reviewers. We extend our sincere thanks for their dedication and continuous support as a reviewer!

Osman Ahmed, Chicago, IL/US

Seyed Ameli-Renani, London/GB

Alessandro Cannavale, Rome/IT
Colin Cantwell, Dublin/IE
Raymond Chung, Singapore/SG
Warren Clements, Melbourne/AU
Francesco Giurazza, Naples/IT
Vincent Helyar, Hampshire/GB
Riccardo Inchingolo, Acquaviva delle Fonti BA/IT

April 2021

CVIR Endovascular has been accepted for indexing in Clarivate Analytics Emerging Sources Citation Index (ESCI). The ESCI was launched in late 2015 by Thomson Reuters as a new database in Web of Science. Since 2017, the index has been produced by Clarivate Analytics. Journals in ESCI have passed an initial editorial evaluation involving rigorous evaluation processes and selection criteria.

The inclusion of CVIR Endovascular in the ESCI is a testament to the level of quality which we seek to provide to the IR community and furthermore improves the visibility of its content to readers.

You can find CVIR Endovascular in Clarivate Analytics Web of Science Master Journal List.

Authors from more than 750 German institutions will be able to publish open access for free with CVIR Endovascular (as of  August 2020). For more details, please visit the Springer website.

Make sure to read the Author Guide before submitting your paper to CVIR Endovascular.

Click below to read the list of eligible institutions that are included in the agreement.

CIRSE offers a 15% discount on the article processing charges (APC)* for CVIR Endovascular to corresponding authors who are CIRSE members in good standing. In order to apply for this discount, please contact CVIR Endovascular’s editorial team at info@cvirendovascular.org before submitting your manuscript.
Please note that the CIRSE discount cannot be combined with an institutional discount, or used for already-published articles.

*CVIR Endovascular currently levies an APC of €1290.00/£1190.00/$1570.00 for each article accepted for publication, plus VAT or local taxes where applicable.  

 CVIR Endovascular is growing very fast, becoming a major journal in the field of vascular IR; therefore, we are expanding our team of expert peer reviewers. We offer the opportunity to IRs to become a new reviewer for the journal.

CVIR Endovascular is especially interested in reviewers who have expertise and interest in the following fields: neurointerventions, gastrointestinal interventional radiology, pulmonary embolism, embolisation and endovascular interventions.  

If you would like to become a reviewer for our journal, please send us your CV and state your area of expertise at info@cvirendovascular.org.

February 2020

CVIR Endovascular is now indexed in PubMed Central (PMC) / PubMed: two prestigious journal indexing and abstracting services and databases from the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM).

This means that the full texts of all articles published in the journal are now available on PMC and the abstracts and citations are available on PubMed. This achievement reflects the growing success of the journal, its high-quality scientific articles, and the diversity and excellence of the editorial board, reviewers and authors. Indexing provides greater exposure and scientific validation for the journal and offers greater discoverability and visibility to our authors.

With its acceptance, CVIR Endovascular joins the league of other prestigious global medical journals who use the PubMed and PMC platforms to disseminate their work to millions of readers around the world who rely on the integrity of the NLM and NIH who curate these indexing services following intense scrutiny of the scientific, editorial and technical quality of its articles.

Open access also means open discussion. Have your say and contribute to scientific discussion on endovascular treatments by submitting a Letter to the Editor critiquing a paper already published in CVIR Endovascular.

APC waivers available for this article type - contact info@cvirendovascular.org for details!

Please note that all case reports are presenting individual patient data and therefore authors need to state that they have a written statement from the patient(s) that he/she gives informed consent for publication. Read more on editorial policies here.

We encourage authors to use the below template for the Consent for Publication statement, which has to be included as part of the Ethics Declarations section:

 “Written informed consent was obtained from the patient for publication of this case report and any accompanying images.”

In the event that your institution does not have an appropriate Consent for Publication form that you can use, please get in touch with us at info@cvirendovascular.org

Peer review is a good opportunity for early career researchers to play a role in the research community and gain valuable experience to help improve your own research writing. If you would like to get involved in peer review and are looking for tips on how to deliver a great review for CVIR Endovascular, we invite you to watch the new webinar produced by Prof. Jim Reekers, Editor-in-Chief.

Direct Transfer of Good Papers from CVIR to CVIR Endovascular

Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be automatically transferred to CVIR Endovascular for consideration.

Thank you to all our readers, authors and reviewers who visited the booth during the "Meet & Greet" sessions, and to those who participated in the "Solve the Case" competition (winners pictured below) for making CIRSE 2019 a great congress for CVIR Endovascular!